|
joy. initial studies with tras-dm1 showed an approx 80% response rate , of the first 15 patients in phase 1 dosed every 3 weeks. 7 of 15 patients showed stable disease. 5 of 15 had a PR or tumor reduction.. only 3 patients of 15 failed to respond at all.. try to relax, I hope and pray it works for you..
Chrissy.. sorry to hear about the LFT's .. a phase 2 weekly dosed trial is starting in july... maybe u need a lower dose of tras-dm1 but more frequent dosings..
run to live
|